Nkarta, Inc. Files Definitive Proxy Statement for June 5 Meeting
Ticker: NKTX · Form: DEF 14A · Filed: Apr 21, 2025 · CIK: 1787400
| Field | Detail |
|---|---|
| Company | Nkarta, INC. (NKTX) |
| Form Type | DEF 14A |
| Filed Date | Apr 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, shareholder-voting
TL;DR
Nkarta's proxy statement is out for the June 5th meeting - shareholders need to vote!
AI Summary
Nkarta, Inc. filed its definitive proxy statement (DEF 14A) on April 21, 2025, for its annual meeting on June 5, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. The company is based in South San Francisco, California, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting and provides information necessary for them to cast their votes on important company matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial or operational distress.
Key Numbers
- 20250605 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
- 20250421 — Filing Date (Date the definitive proxy statement was submitted to the SEC.)
Key Players & Entities
- Nkarta, Inc. (company) — Registrant
- 0001140361-25-014740 (filing_id) — Accession Number
- 20250421 (date) — Filing Date
- 20250605 (date) — Meeting Date
- South San Francisco, CA (location) — Company Headquarters
FAQ
What is the purpose of this DEF 14A filing?
The purpose is to solicit proxies from shareholders for the annual meeting of Nkarta, Inc. to be held on June 5, 2025.
When is Nkarta, Inc.'s annual meeting scheduled?
The annual meeting is scheduled for June 5, 2025.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on April 21, 2025.
Where is Nkarta, Inc. headquartered?
Nkarta, Inc. is headquartered at 1150 Veterans Boulevard, South San Francisco, CA 94080.
What industry does Nkarta, Inc. operate in?
Nkarta, Inc. operates in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 21, 2025 regarding Nkarta, Inc. (NKTX).